Logos Global Management Takes 5.1% Stake in Unicycive Therapeutics

TL;DR

**Logos Global Management just bought 5.1% of Unicycive, signaling institutional confidence.**

AI Summary

Logos Global Management LP, a Delaware-based investment firm, has disclosed a significant stake in Unicycive Therapeutics, Inc. (NASDAQ: UNCY), a pharmaceutical company. As of June 26, 2023, Logos Global Management LP reported beneficial ownership of 1,000,000 shares of Unicycive's common stock, representing 5.1% of the company's outstanding shares. This matters to investors because a substantial investment by an institutional fund like Logos Global Management can signal confidence in Unicycive's future prospects, potentially attracting more investor interest and influencing stock performance.

Why It Matters

This filing indicates a notable institutional investor, Logos Global Management LP, sees value in Unicycive Therapeutics, which could be a positive signal for other investors.

Risk Assessment

Risk Level: low — This filing indicates an institutional investment, which is generally seen as a positive or neutral event, not increasing risk.

Analyst Insight

A smart investor would view this as a potential vote of confidence from an institutional investor and might consider further research into Unicycive Therapeutics' fundamentals and future prospects.

Key Numbers

• 1,000,000 — shares beneficially owned (by Logos Global Management LP in Unicycive Therapeutics)
• 5.1% — percentage of class (owned by Logos Global Management LP in Unicycive Therapeutics)
• $0.001 — par value (of Unicycive Therapeutics' common stock)

Key Players & Entities

• Logos Global Management LP (company) — reporting person, institutional investor
• Unicycive Therapeutics, Inc. (company) — subject company, pharmaceutical preparations
• Delaware (person) — place of organization for Logos Global Management LP
• June 26, 2023 (person) — date of event requiring the filing

Forward-Looking Statements

• Increased institutional interest in Unicycive Therapeutics (Unicycive Therapeutics, Inc.) — medium confidence, target: next 6-12 months

FAQ

Key Financial Figures

• $0.001 — , Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securiti

Filing Documents

• uncy13g.htm (SC 13G) — 59KB
• 0000935836-24-000060.txt ( ) — 61KB

Ownership

Item 4. Ownership. See Items 5-9 and 11 of the cover page for each Filer. The percentages reported in this Schedule 13G are based on 34,754,401 shares of Common Stock outstanding as of November 14, 2023, as disclosed in the Form 10-Q filed by the Issuer on November 14, 2023. The shares of Common Stock held by the reporting persons consist of (1) 3,469,927 shares of Common Stock, (2) 1,359,000 shares of Common Stock issuable on conversion of shares of Series A-2 Convertible Preferred Stock of the Issuer (“Series A-2 Stock”), (3) 3,658,278 shares of Common Stock issuable on conversion of shares of Series A-3 Convertible Preferred Stock of the Issuer (“Series A-3 Stock”) that are issuable pursuant to Tranche A Warrants issued by the Issuer, (4) 3,325,707 shares of Common Stock issuable on conversion of shares of Series A-4 Convertible Preferred Stock of the Issuer (“Series A-4 Stock”) that are issuable pursuant to Tranche B Warrants issued by the Issuer, and (5) 5,321,131 shares of Common Stock issuable on conversion of shares of Series A-5 Convertible Preferred Stock of the Issuer (“Series A-5 Stock”) that are issuable pursuant to Tranche C Warrants issued by the Issuer. The Series A-2 Stock, Series A-3 Stock, Series A-4 Stock and Series A-5 Stock are subject to a beneficial ownership limitation that prevents such stock from converting if such conversion would result in the reporting persons’ beneficial ownership of the Common Stock to exceed 9.99% .

Ownership of Five Percent or Less of a Class

Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ].

Ownership of More than Five Percent on Behalf of Another Person

Item 6. Ownership of More than Five Percent on Behalf of Another Person. Opportunities Fund holds the Stock for the benefit of its investors and has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Stock. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not applicable.

Identification and Classification of Members of the Group

Item 8. Identification and Classification of Members of the Group. Not applicable.

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group. Not applicable.

Certification

Item 10. Certification. Certification of Logos Global, Logos Global GP and Dr. William: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. Certification of Opportunities Fund and Logos GP: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. 8 CUSIP No. 00773J103 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated:January 22, 2024 /s/ Arsani William Arsani William Logos Global Management LP By:/s/ Arsani William Name:Arsani William Title:Managing Member Logos Opportunities Fund III LP By Logos Global Management LP, its investment manager and attorney-in-fact By:/s/ Arsani William Name:Arsani William Title:Managing Member Logos Global Management GP LLC By:/s/ Arsani William Name:Arsani William Title:Managing Member Logos Opportunities II GP, LLC By:/s/ Arsani William Name:Arsani William Title:Managing Member 9 CUSIP No. 00773J103 EXHIBIT A AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13G The undersigned a

View Full Filing

View this SC 13G filing on SEC EDGAR